Country: Israel
Language: English
Source: Ministry of Health
NONOXINOL 9; RICINOLEIC ACID
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
G02BB
OVULES
NONOXINOL 9 140 MG; RICINOLEIC ACID 25 MG
VAGINAL
Not required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
INTRAVAGINAL CONTRACEPTIVES
Spermicide for the control of conception.
2012-12-31
GLOVAN 26. 11. 2007 RH " ע עבקנ הז ןולע טמרופ " רשואו קדבנ ונכותו תואירבה דרשמ י ." רשואמ ןולע : רבמבונ 2007 . “This leaflet format has been determined by the Ministry of Health and the content thereof has been checked and approved.” Date of approval: November 2007. GLOVAN VAGINAL OVULES COMPOSITION Each vaginal ovule contains: _Active Ingredient _ _ _Nonoxynol 9 140 mg Ricinoleic acid 25 mg_ _ _ _ _Other Ingredients _ Witepsol W-35, polysorbate 61, lactic acid. MECHANISM OF ACTION Glovan is a topical spermicide. Nonoxynol-9 is responsible for cell membrane breakage; it decreases surface tension and kills epithelial cells. Following insertion into the vagina, the Glovan ovule dissolves and provides protective contraceptive coverage of the vaginal vault. Glovan is not 100% effective in contraception. Glovan is used either in conjunction with a vaginal diaphragm or as the sole method of contraception. INDICATIONS Spermicide contraceptive. CONTRAINDICATIONS Known hypersensitivity to either of the components of the preparation. Vaginal anesthesia, as in spinal cord injuries. Pregnancy. WARNINGS Before using Glovan, pregnancy should be ruled out (see Contraindications). Use of Glovan does not preclude the possibility of contraception. Patients should be advised to report if a menstrual period is missed. Vaginal contraceptives containing nonoxynol 9 do not protect against infection from HIV (human immunodeficiency virus, the AIDS virus) or other sexually transmitted diseases (STDs). Use of vaginal contraceptives containing nonoxynol 9 can increase vaginal irritation, which may actually increase the possibility of transmitting the AIDS virus and other STDs from infected partners. _Use in Pregnancy and Lactation _ There is no evidence from animal and human studies that nonoxynol 9 is teratogenic. Human epidemiological studies have not shown any firm evidence of adverse effects on the foetus, however some studies have shown that nonoxynol 9 may be embryotoxic i Read the complete document